Skip to content

Comparing two drugs Aceclofenac and Flupirtine for pain relief

Comparsion of Flupritine and Aceclofenac for post-operative analgesia in mandibular trauma A Randomized Control Trial - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100035
Enrollment
36
Registered
2026-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K14- Diseases of oral cavity and salivary glands

Interventions

Intervention1: Cap Flupirtine: Cap.Flupirtine 100 mg TDS for 1st 48 hours by oral route and then SOS till 7th day by oral route.It is one of the first drug of the class of selective neuronal potassium

Sponsors

Sanjay Gandhi Institute of Trauma and Orthopaedics
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who have given written informed consent to be a part of the study. 2. Patients in the age group between 18 to 65 years, of either sex. 3. Patients of ASA group I and II. 4. Patients planned for Open reduction and internal fixation for treatment of Maxillofacial Trauma. 5. Patients with no history of systemic disorders and any other mental illness.

Exclusion criteria

Exclusion criteria: 1.Patients with severe debilitating conditions such as uncontrolled diabetes mellitus, uncontrolled hypertension, cardio respiratory conditions, previous history of cerebrovascular accidents, myocardial infarction, coronary artery disease, impaired renal and hepatic function. 2.All pregnant and lactating females. 3.Patients on antiplatelet/anticoagulant therapy. 4.Any history of opium addiction. 5.Patients with concomitant head injuries, cervical spine injuries or debilitating thoracic or abdominal trauma. 6.Patient with known allergy to Aceclofenac and Flupirtine.

Design outcomes

Primary

MeasureTime frame
To evaluate the analgesic efficacy of Flupirtine 100 mg TDS administered orally in Post Operative mandibular Trauma patients.Timepoint: To evaluate the analgesic efficacy of Flupirtine 100 mg TDS administered orally in Post Operative mandibular Trauma patients.

Secondary

MeasureTime frame
pain using NRS scale in both the study groups postoperatively.Timepoint: pain using NRS scale postoperatively at 0,1,2,4,6,8,10,12,24,48,72 hours, 5th and 7th day.;To evaluate and compare time weighted sum pain intensity difference (SPID)Timepoint: at 0,1,2,4,6,8,10,12,24,48 hours.;To calculate and compare total pain relief (TOTPAR) in both study groupsTimepoint: at different time intervals till 48 hours.;preoperative hemodynamic parameters like Pulse rate, Systolic Blood Pressure, Diastolic Blood Pressure with postoperativeTimepoint: at 0,2,4,6,8,10,12 hours with in both the study groups.;pain at function in both the study groups postoperativelyTimepoint: at 0,24,48,72 hours and 7th day;onset of analgesia postoperatively after administration of both the drugs to their respective study groupsTimepoint: after administration ;postoperative complications like nausea, vomiting (with Impact scale) post operative bleeding, abdominal discomfort, dizziness in both the study groups.Timepoint: postoperatively;Liver function test levels (SGPT, SGOT, ALP) postoperativelyTimepoint: postoperatively at 48 hours and on 7th day.;quality of life postoperatively using QHIP-14 questionnaire in both study groups.Timepoint: postoperratively

Countries

India

Contacts

Public ContactDr. Harshitha R

Sanjay Gandhi Institute of Trauma and Orthopedics

abhinandanpatel@yahoo.co.in9845293489

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026